United Against Antimicrobial Resistance (AMR): Can Bangladesh Turn a Five-Year Strategy into a National Defense?
From policy recognition to coordinated action: Bangladesh’s new strategic framework offers a historic opportunity to confront AMR through a One Health approach linking human health, animals, food systems, agriculture, environment, and communities
A Silent Crisis That Could Undermine Modern Medicine
A patient arrives at a hospital with pneumonia. The doctor prescribes a commonly used antibiotic. Days later, there is no improvement. A second medicine is prescribed. Then a third. The infection becomes harder to control, the hospital stay becomes longer, treatment costs rise, and a family that was already vulnerable begins facing financial pressure.
At the same time, thousands of kilometres away, antibiotics may be used routinely on a poultry farm to prevent disease caused by weak biosecurity. In an aquaculture pond, antimicrobial medicines may be used without adequate diagnosis. Pharmaceutical residues and resistant organisms may eventually enter food systems, water bodies, and the wider environment.
These events may appear disconnected. They are not.
They represent one interconnected challenge: antimicrobial resistance (AMR).
When bacteria and other microorganisms develop the ability to survive medicines designed to eliminate them, infections that were once easily treatable become more difficult, expensive, and sometimes impossible to cure.
AMR threatens far more than infectious disease treatment. Modern surgery, cancer care, intensive care, maternal healthcare, tuberculosis treatment, organ transplantation, and childhood disease management all depend on effective antimicrobial medicines.
The question facing Bangladesh is no longer whether AMR is a serious threat. The question is whether the country can build the coordinated national response required to preserve these life-saving medicines for future generations.
A Historic Policy Shift: AMR Enters Bangladesh’s Development Agenda
Bangladesh’s Five-Year Strategic Framework for Reform and Development, July 2026–June 2031, represents an important policy milestone by recognising AMR not simply as a healthcare issue but as a national development challenge.
Prepared by the General Economics Division of the Planning Commission and approved by the National Economic Council in May 2026, the framework places AMR within a broader strategy of national reform and development.
After sustained advocacy by civil society organisations and stakeholders, the Government of Bangladesh has explicitly incorporated antimicrobial resistance into the country’s five-year strategic planning framework.
This recognition deserves appreciation. However, policy recognition is only the beginning.
The real challenge is implementation. The success of Bangladesh’s AMR response will depend on whether institutions that traditionally work separately can function as one coordinated system.
Because AMR does not follow administrative boundaries.
A resistant bacteria does not know whether it originated in a hospital, poultry farm, fish pond, pharmaceutical factory, wastewater system, or community.
Therefore, Bangladesh’s response cannot remain divided between ministries and sectors.
It must become a national defence system based on the One Health approach. The Problem: AMR Is Not Only a Health Issue. Public discussion on antibiotic resistance often focuses on one important message:
Do not misuse antibiotics. That message remains essential. However, it represents only one part of a much larger challenge. AMR develops and spreads through interconnected systems:
human healthcare;
livestock production;
poultry farming;
aquaculture;
food supply chains;
pharmaceutical manufacturing;
wastewater management;
environmental ecosystems.
A hospital may improve antibiotic prescribing practices, but if resistant organisms continue to develop and circulate through other sectors, the national challenge remains unresolved. The new framework’s most significant contribution is recognising this reality.
It shifts the question from: “How can we reduce inappropriate antibiotic use among patients and doctors?”
to:
“How can we reduce the social, economic, agricultural, and environmental conditions that create and spread resistance?”
That is the essence of One Health. The Warning Signs Are Already Visible
The framework describes AMR as a “silent multiplier of failure” because it increases vulnerability across the entire health system.
If antibiotics lose effectiveness:
routine infections become more dangerous; medical procedures become riskier; hospital costs increase; families face greater financial pressure; healthcare systems become less resilient.
The framework highlights concerning resistance trends, including rising resistance to critically important antibiotics and the spread of resistant organisms associated with bloodstream infections.
These indicators are not merely scientific statistics. They represent future risks to public health, healthcare affordability, and national development. AMR is therefore not only a medical challenge.
It is a challenge to human security and economic resilience. The Opportunity: Moving from Plans to Measurable Results. One of the strengths of Bangladesh’s new framework is its focus on measurable action. The first phase, Recovery, proposes foundational reforms, including:
operationalising a National One Health Secretariat with budgetary authority;
expanding AMR surveillance networks;
conducting prescribing surveys;
establishing antimicrobial stewardship committees;
strengthening national AMR data systems linked with global surveillance platforms.
This approach is important because effective policy requires reliable evidence.
A country cannot regulate what it cannot measure.
Without accurate information about antibiotic prescribing, sales, consumption patterns, resistance trends, and environmental contamination, regulation becomes guesswork.
The Real Test: Implementation and Enforcement
The second phase, Restoration, moves beyond institutional development toward practical enforcement.
The framework proposes:
pharmacy audits;
updated treatment guidelines;
antimicrobial stewardship education for medical and veterinary professionals;
digital prescription systems;
restrictions on antibiotic growth promoters in animal feed;
residue testing in poultry and aquaculture;
nationwide awareness campaigns through SMS, community radio, and schools.
These measures recognise an important reality:
AMR is not only a medical problem.
It is also:
a behaviour problem;
a market problem;
a governance problem.
People seek antibiotics because they want quick recovery. Pharmacies may sell antibiotics because demand exists. Farmers may use antibiotics because disease outbreaks can destroy livelihoods.
Therefore, reducing AMR requires changing incentives throughout society. Primary Healthcare Must Strengthen Alongside Regulation. A major challenge will be balancing regulation with access. Restricting non-prescription antibiotic sales is necessary. However, many citizens rely on pharmacies as their first healthcare point because consultations may be costly, distant, or unavailable.
If regulation is introduced without improving affordable primary healthcare services, vulnerable communities may face new barriers.
Sustainable AMR control requires both: responsible antibiotic regulation and accessible healthcare alternatives. Agriculture and Fisheries Are Central to the Solution. The livestock sector is a critical part of Bangladesh’s AMR response.
Farmers often use antibiotics not because they ignore the risks, but because they face real economic pressures. Disease outbreaks can destroy entire poultry farms or livestock operations.
Therefore, reducing antibiotic dependency requires investment in:
vaccination;
veterinary services;
biosecurity;
diagnostics;
improved farm management.
The principle is simple:
To reduce antibiotic use, Bangladesh must also reduce infections. The same applies to aquaculture. Bangladesh’s fisheries sector supports livelihoods, nutrition, and exports. But sustainable growth requires:
fish disease surveillance;
early warning systems;
vaccine access;
water-quality monitoring;
responsible antimicrobial practices.
Regulation alone is insufficient. Farmers and producers need practical alternatives.
The Environment: The Missing Link in AMR Control. The environmental dimension of AMR has historically received less attention. However, antibiotic residues and resistant organisms can move through:
wastewater;
rivers;
agricultural land;
food systems.
The framework’s proposal for stronger wastewater treatment requirements in pharmaceutical zones, poultry farms, and aquaculture facilities is therefore a significant step. Environmental protection must become a core pillar of One Health.
Not a supporting element.
Not an afterthought.
Community Awareness and Communication Matter
The framework’s emphasis on SMS, community radio, and school-based awareness provides an important opportunity. Community communication should go beyond simple messages about antibiotic misuse.
Bangladesh needs antibiotic literacy. Awareness tells people that AMR exists. Literacy helps people understand:
when antibiotics are needed;
when they are harmful;
why completing treatment matters;
how prevention reduces antibiotic dependence.
Community radio, local organisations, health workers, farmers’ networks, and digital platforms can play a powerful role in building this understanding. Digital Technology Can Support AMR Action, But Governance Comes First. The framework proposes stronger digital health information systems and integration of AMR surveillance data.
Technology can support:
identifying resistance trends;
monitoring antibiotic consumption;
improving decision-making;
strengthening early warning systems.
However, technology cannot replace institutional discipline. A dashboard cannot compensate for poor laboratory data. Artificial intelligence cannot solve incomplete reporting.
Digital tools are only as effective as the systems behind them. The foundation must remain:
quality data, accountability, and coordinated governance.
By 2031, Success Must Be Measured by Outcomes
Bangladesh should avoid measuring AMR progress only through:
number of meetings held;
committees formed;
workshops conducted;
people trained.
Those are activities.
The real question is whether outcomes improve.
By 2031, Bangladesh should be able to answer:
Are unnecessary antibiotic sales decreasing?
Are hospitals improving antibiotic stewardship?
Are resistance trends stabilising?
Are antibiotic residues declining in food systems?
Are families facing fewer treatment failures?
Success must be measured by healthier people and stronger systems.
Call for Continued Action: A National Movement Against AMR
The greatest strength of Bangladesh’s new framework is its recognition that no single ministry can solve AMR.
Doctors, veterinarians, farmers, pharmacists, researchers, regulators, journalists, community organisations, and citizens all have roles to play.
A successful One Health response requires:
strong governance;
sustainable financing;
reliable surveillance;
institutional accountability;
public participation.
The next five years represent a critical opportunity.
Bangladesh has moved from recognising AMR as a problem to including it in national planning.
Now the country must move from commitment to implementation. Because microbes do not recognise boundaries between ministries. Bangladesh’s response to antimicrobial resistance cannot afford to recognise them either.
The fight against AMR is not only about protecting medicines. It is about protecting lives, livelihoods, food security, healthcare systems, and the future resilience of Bangladesh.
United Against AMR means acting together, before resistance becomes irreversible
By AHM Bazlur Rahman, Chief Executive Officer, Bangladesh NGOs Network for Radio and Communication (BNNRC), & Ambassador for Antimicrobial Resistance (AMR) for Bangladesh, BNNRC Member, AMR Multi-Stakeholder Partnership Platform (AMR-MSPP)